U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577934) titled 'Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block' on April 21.
Brief Summary: This is a single-center, randomized, single-blind, parallel-group clinical trial. The study aims to compare the analgesic efficacy of liposomal bupivacaine versus ropivacaine for transversus abdominis plane (TAP) block in patients undergoing laparoscopic cholecystectomy. Eligible participants will be randomly assigned to receive either liposomal bupivacaine or ropivacaine for TAP block during surgery. The primary outcome is the dynamic NRS pain score at 24 hours after surgery. Secondary outcomes include static and dynamic NRS pain sco...